In Practice
Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
Abstract
Fungal co-infections, especially with Aspergillus and Candida species, are prevalent in hospitalised COVID-19 patients, and could influence patient outcomes and hamper treatment efforts. However, information about and elucidation of the causal relationship between fungal co-infections and COVID-19 disease outcomes or severity in patients are still lacking. Such information, if and when available, will help facilitate appropriate case management.
Authors' affiliations
O T Ezeokoli, Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa
C H Pohl, Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa
Full Text
PDF (149KB)Keywords
Cite this article
Article History
Date published: 2020-10-06
Article Views
Full text views: 1269
Comments on this article
*Read our policy for posting comments here